Advertisement

When Could Preoperative Radiotherapy Be Proposed for cT2 Presentations?

  • Karyn A. Goodman
Chapter

Abstract

In contrast to locally advanced (T3-T4 or N positive) rectal cancer, for which preoperative chemoradiation has become the standard of care [29], treatment of earlier-stage rectal cancer, such as clinically staged T2N0 disease, is less well established. The gold standard for a cT2N0 rectal tumor remains a radical resection with a total mesorectal excision to remove the rectum and draining mesorectal lymph nodes, but for low-lying tumors, this may entail an abdominoperineal resection and permanent colostomy, which can be associated with long-term effects on quality of life and poor body image [15, 17]. Even sphincter-preserving options, such as a low anterior resection with a coloanal anastomosis, may lead to impaired bowel function [17, 19]. Patient-reported quality-of-life data after treatment for rectal cancer have demonstrated permanent detrimental effects on patients’ bowel functioning, particularly in patients with stomas or low rectal anastomoses [5, 10, 35].

References

  1. 1.
    Blumberg D, Paty PB, Guillem JG et al (1999) All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 42:881–885CrossRefPubMedGoogle Scholar
  2. 2.
    Brodsky JT, Richard GK, Cohen AM et al (1992) Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 69:322–326CrossRefPubMedGoogle Scholar
  3. 3.
    Brown G, Richards C, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371–377CrossRefPubMedGoogle Scholar
  4. 4.
    Chakravarti A, Compton CC, Shellito PC et al (1999) Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 230:49–54CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Engel J, Kerr J, Schlesinger-Raab A et al (2003) Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 238:203–213PubMedPubMedCentralGoogle Scholar
  6. 6.
    Fernández-Esparrach G, Ayuso-Colella JR, Sendino O et al (2011) EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study. Gastrointest Endosc 74(2):347–354CrossRefPubMedGoogle Scholar
  7. 7.
    Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298–304CrossRefPubMedGoogle Scholar
  8. 8.
    Garcia-Aguilar J, Shi Q, Thomas CR Jr et al (2012) A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 19:384–391CrossRefPubMedGoogle Scholar
  9. 9.
    Greenberg JA, Shibata D, Herndon JE 2nd et al (2008) Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum 51:1185–1191. discussion 1191-1194CrossRefPubMedGoogle Scholar
  10. 10.
    Grumann MM, Noack EM, Hoffmann IA, Schlag PM (2001) Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 233:149–156CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Guillem JG, Chessin DB, Cohen AM et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829–836. discussion 836-838CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Habr-Gama A, Perez RO, Nadalin W et al (2005) Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 9:90–99. discussion 99-101CrossRefPubMedGoogle Scholar
  13. 13.
    Habr-Gama A, Perez RO, Proscurshim I et al (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10:1319–1328. discussion 28-29CrossRefPubMedGoogle Scholar
  14. 14.
    Heafner TA, Glasgow SC (2014) A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastroisntest Oncol 5(5):345–352Google Scholar
  15. 15.
    Hendren SK, O’Connor BI, Liu M et al (2005) Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 242:212–223CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Janjan NA, Crane C, Feig BW et al (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107–112CrossRefPubMedGoogle Scholar
  17. 17.
    Kasparek MS, Hassan I, Cima RR et al (2011) Quality of life after coloanal anastomosis and abdominoperineal resection for distal rectal cancers: sphincter preservation vs quality of life. Color Dis 13:872–877CrossRefGoogle Scholar
  18. 18.
    Kim JH, Beets GL, Kim M-J, Kessels AGH, Beets-Tan RGH (2004) High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to size? Eur J Radiol 52:78–83CrossRefPubMedGoogle Scholar
  19. 19.
    Lange MM, den Dulk M, Bossema ER et al (2007) Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg 94:1278–1284CrossRefPubMedGoogle Scholar
  20. 20.
    Maas M, Beets-Tan RG, Lambregts DM et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640CrossRefPubMedGoogle Scholar
  21. 21.
    Moreno CC, Sullivan PS, Kalb BT et al (2015) Magnetic resonance imaging of rectal cancer: staging and restaging evaluation. Abdom Imaging 40(7):2613–2629CrossRefPubMedGoogle Scholar
  22. 22.
    NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450CrossRefGoogle Scholar
  23. 23.
    Paty PB, Nash GM, Baron P, Zakowski M et al (2002) Long-term results of local excision for rectal cancer. Ann Surg 236(4):522–529. discussion -530CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Rengan R, Paty P, Wong WD et al (2005) Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection? J Clin Oncol 23(22):4905–4912CrossRefPubMedGoogle Scholar
  25. 25.
    Rödel C, Martus P, Papadoupolos T et al (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23(34):8688–8696CrossRefPubMedGoogle Scholar
  26. 26.
    Rothenberger DA, Garcia-Aguilar J (2000) Role of local excision in the treatment of rectal cancer. Semin Surg Oncol 19(4):367–375CrossRefPubMedGoogle Scholar
  27. 27.
    Ruo L, Tickoo S, Klimstra DS et al (2002) Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 236:75–81CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Russell AH, Harris J, Rosenberg PJ et al (2000) Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 46:313–322CrossRefPubMedGoogle Scholar
  29. 29.
    Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMedGoogle Scholar
  30. 30.
    Smith JD, Ruby JA, Goodman KA et al (2012) Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 256:965–972CrossRefPubMedGoogle Scholar
  31. 31.
    Steele GD Jr, Herndon JE, Bleday R et al (1999) Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 6:433–441CrossRefPubMedGoogle Scholar
  32. 32.
    Vecchio FM, Valentini V, Minsky BD et al (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752–760CrossRefPubMedGoogle Scholar
  33. 33.
    Wang R, Wu P, Shi D et al (2014) Risk factors of synchronous inguinal lymph nodes metastasis for lower rectal cancer involving the anal canal. PLoS One 9:e111770CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Willett CG, Compton CC, Shellito PC et al (1994) Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 73:2716–2720CrossRefPubMedGoogle Scholar
  35. 35.
    Wilson TR, Alexander DJ (2008) Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. Br J Surg 95:1408–1415CrossRefPubMedGoogle Scholar
  36. 36.
    You YN, Baxter NN, Stewart A, Nelson H (2007) Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg 245(5):726–733CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    You YN (2011) Local excision: is it an adequate substitute for radical resection in T1/T2 patients? Semin Radiat Oncol 21:178–184CrossRefPubMedGoogle Scholar
  38. 38.
    Zhou J, Zhan S, Zhu Q et al (2014) Prediction of nodal involvement in primary rectal carcinoma without invasion to pelvic structures: accuracy of preoperative computed tomography, MR, and DWIBS assessments relative to histopathologic findings. PLoS One 9(4):e92779CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  1. 1.University of Colorado Cancer Center, Department of Radiation Oncology, University of Colorado School of MedicineAuroraUSA

Personalised recommendations